Neville Rodie & Shaw Inc Matinas Bio Pharma Holdings, Inc. Transaction History
Neville Rodie & Shaw Inc
- $1.32 Billion
- Q2 2024
A detailed history of Neville Rodie & Shaw Inc transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 1,157,332 shares of MTNB stock, worth $196,746. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,157,332
Previous 1,157,332
-0.0%
Holding current value
$196,746
Previous $314,000
41.72%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding MTNB
# of Institutions
45Shares Held
26MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA9.32MShares$1.58 Million0.0% of portfolio
-
Sargent Investment Group, LLC3.61MShares$613,7850.22% of portfolio
-
Black Rock Inc. New York, NY2.48MShares$422,0080.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$363,0270.0% of portfolio
-
Alliance Wealth Management Group Flemington, NJ1.89MShares$320,7410.08% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $36.9M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...